Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
sox0407's Profile
Displaying 351-400 of 2184 result(s).
IPIX Innovation Pharmaceuticals Inc
04/18/2018 8:20:05 PM
I honestly want to know how one can (1)
IPIX Innovation Pharmaceuticals Inc
04/18/2018 6:10:14 PM
Drugs Coming Off Patent by 2022 htt
IPIX Innovation Pharmaceuticals Inc
04/18/2018 5:53:32 PM
Sincere question. How do you know t
IPIX Innovation Pharmaceuticals Inc
04/18/2018 5:51:29 PM
New investors, the statement "33% o (2)
IPIX Innovation Pharmaceuticals Inc
04/17/2018 9:31:23 PM
People who gave a sh*t thanked me i (6)
IPIX Innovation Pharmaceuticals Inc
04/17/2018 9:19:43 PM
I consolidated the results and stic (5)
IPIX Innovation Pharmaceuticals Inc
04/17/2018 9:07:03 PM
I don’t like it when you keep tel (5)
IPIX Innovation Pharmaceuticals Inc
04/17/2018 6:25:37 PM
Ah, back to insulting me by saying
IPIX Innovation Pharmaceuticals Inc
04/17/2018 5:56:02 PM
New investors, the statement "46% o (2)
IPIX Innovation Pharmaceuticals Inc
04/17/2018 4:53:29 PM
Alan, longs I know don't report eve
IPIX Innovation Pharmaceuticals Inc
04/17/2018 4:45:23 PM
Naked shorts! 100% of shares are na
IPIX Innovation Pharmaceuticals Inc
04/17/2018 4:05:56 PM
The premise of ~100% short is if th
IPIX Innovation Pharmaceuticals Inc
04/17/2018 3:57:29 PM
Your words of "since longs are not
IPIX Innovation Pharmaceuticals Inc
04/17/2018 3:29:24 PM
Thanks for the explanations, I real (1)
IPIX Innovation Pharmaceuticals Inc
04/17/2018 2:05:13 PM
4kids, you've been saying non-retai (1)
IPIX Innovation Pharmaceuticals Inc
04/17/2018 1:59:30 PM
Alan, I see you are using longs you (3)
IPIX Innovation Pharmaceuticals Inc
04/16/2018 7:09:13 PM
Your concern is legitimate, but not
IPIX Innovation Pharmaceuticals Inc
04/16/2018 6:24:47 PM
57% seems high if your wash trade s
IPIX Innovation Pharmaceuticals Inc
04/16/2018 6:18:52 PM
New investors, the statement "57% o (2)
IPIX Innovation Pharmaceuticals Inc
04/16/2018 2:27:28 PM
sox040713 Monday, 04/16/18 02:24:27 (2)
IPIX Innovation Pharmaceuticals Inc
04/16/2018 1:26:46 PM
Two interesting posts by PP on Prur (2)
IPIX Innovation Pharmaceuticals Inc
04/15/2018 6:27:42 PM
BP's interests in the Big Three “ (6)
IPIX Innovation Pharmaceuticals Inc
04/15/2018 4:14:12 PM
IPIX Clinical Trial Summaries B-OM (9)
IPIX Innovation Pharmaceuticals Inc
04/13/2018 7:48:16 PM
New investors, the statement "45% o (4)
IPIX Innovation Pharmaceuticals Inc
04/12/2018 9:34:03 PM
New investors, the statement "38% o (4)
IPIX Innovation Pharmaceuticals Inc
04/12/2018 6:15:05 PM
IPIX Corporate Overview (April 2018 (3)
IPIX Innovation Pharmaceuticals Inc
04/11/2018 8:09:57 PM
New investors, the statement "20% o (5)
IPIX Innovation Pharmaceuticals Inc
04/10/2018 6:40:25 PM
New investors, the statement "42% o (3)
IPIX Innovation Pharmaceuticals Inc
04/10/2018 4:12:59 PM
Basher like Amatuer said Leo doesnâ (4)
IPIX Innovation Pharmaceuticals Inc
04/10/2018 4:07:28 PM
Article - HMB/Arg/Gln Does Not Redu (3)
IPIX Innovation Pharmaceuticals Inc
04/10/2018 12:10:40 AM
New investors, the statement "48% o (5)
IPIX Innovation Pharmaceuticals Inc
04/09/2018 7:36:16 PM
Another email shared by Wild. WILD_ (3)
IPIX Innovation Pharmaceuticals Inc
04/09/2018 7:25:55 PM
Again using the post you linked, th
IPIX Innovation Pharmaceuticals Inc
04/09/2018 7:13:40 PM
Alan, my mistake on your timing. Yo (1)
IPIX Innovation Pharmaceuticals Inc
04/09/2018 6:57:26 PM
I view those gangs as penny flipper (1)
IPIX Innovation Pharmaceuticals Inc
04/09/2018 4:59:42 PM
The SP was ~$5 at one point, so the
IPIX Innovation Pharmaceuticals Inc
04/09/2018 4:39:03 PM
Thanks for posting it here. Here’
IPIX Innovation Pharmaceuticals Inc
04/09/2018 4:27:46 PM
Although today’s PR is positive, (3)
IPIX Innovation Pharmaceuticals Inc
04/09/2018 3:25:07 PM
My guess is the additional analysis (2)
IPIX Innovation Pharmaceuticals Inc
04/09/2018 12:34:55 PM
News - Innovation Pharmaceuticals P (3)
IPIX Innovation Pharmaceuticals Inc
04/07/2018 6:11:20 PM
Phteven C’s last post - 3/25/2018 (1)
IPIX Innovation Pharmaceuticals Inc
04/07/2018 4:13:42 PM
You should also consider when the c (1)
IPIX Innovation Pharmaceuticals Inc
04/07/2018 3:28:08 PM
That's a good idea. I'll work on it (1)
IPIX Innovation Pharmaceuticals Inc
04/07/2018 3:27:35 PM
I knew the idea was suggested by so
IPIX Innovation Pharmaceuticals Inc
04/07/2018 3:15:17 PM
Kevetrin’s p53 modulation in ovar (2)
IPIX Innovation Pharmaceuticals Inc
04/07/2018 3:13:06 PM
Prurisol efficacy signal (Phase 2a,
IPIX Innovation Pharmaceuticals Inc
04/07/2018 3:11:41 PM
Before and after endoscopic images
IPIX Innovation Pharmaceuticals Inc
04/07/2018 3:10:02 PM
B-OM Kaplan-Meier Curves https://in
IPIX Innovation Pharmaceuticals Inc
04/07/2018 3:04:57 PM
Leo decided to change the company n (1)
IPIX Innovation Pharmaceuticals Inc
04/07/2018 2:40:30 PM
I continue to disagree that when th (1)
Go to page:
  • << First
  • < Previous
  • 7
  • 8
  • Next >

Recent Articles

  • Innovative Starter Kit Introduced for Autonomous Vehicle Development
  • Heath Riles BBQ Triumphs at Prestigious Barbecue Championship
  • Canton Fair's Innovation Forum: Fashion Trends and AI Impact
  • Orbia Advance Corporation's Successful Tender Offer Summary
  • Rumble Applauds Trump's Visa Restrictions on Censorship
  • Celebrating Global Partnerships: A Look at Jinan's Initiative
  • Canton Fair Forum Explores Future of Fashion with AI Insights
  • Viatris Inc. Shareholders Encouraged to Take Action Now
  • Kuehn Law Investigates Bakkt Holdings, Inc. Shareholder Concerns
  • Super League Enterprise Begins New Public Offering Initiative
  • Cascades Secures $400 Million in Senior Notes for Growth
  • AsyncHealth's AI-Driven Crowdfunding to Transform Mental Health
  • Court Ruling Enhances Water Management and Community Trust
  • Elevate Your Wedding Memories with Arch Wedding Studio Services
  • Nxera Pharma Welcomes Neurocrine's Phase 2 Study Breakthrough
  • FOBI AI Inc. Strategically Sells German Subsidiary for Growth
  • GreenPower Secures Funding for Growth with New Loan Offering
  • Jena Acquisition Corporation II Launches $200 Million IPO Effort
  • Experience the Blue Danube Waltz Event in New York City
  • Journey of Anti-Fascist Literature: A Global Perspective
  • Rakovina Implements Unique Share Issuance for Debentureholders
  • Strategic Appointment of Mitch Williams as CIO to Transform Streamex
  • CWEA Awards Celebrate Exceptional Leadership in Water Quality
  • Banco Macro Reports Strong Q1 2025 Financial Performance
  • Aberdeen Investments Shareholders Gather for Annual Meeting Results
  • Celebrating Excellence: CWEA's Honorees Transform Water Safety
  • CF Energy's Financial Performance and Strategic Vision for 2025
  • AIP Realty Trust Delivers Promising Performance in Q1 2025
  • Gastops Partners with RTX to Innovate Monitoring Solutions
  • Exploring Legal Actions for Open Lending Corporation Investors
  • Investigation Launched for SelectQuote, Inc. Shareholders
  • Fate Therapeutics to Present Breakthrough CAR T-cell Study Data
  • Metropolitan Animal Specialty Hospital Transition to New Ownership
  • Brakes Plus Expands Its Presence with New Oklahoma Location
  • Artivion Completes $99.5 Million Note Exchange for Stock
  • Grays Peak and Valore Ventures Strengthen Automation Giants
  • Kneat's Annual Meeting: Shareholder Votes and Company Insights
  • Hi-View's Strategic Private Placement for Growth Opportunities
  • Alimentation Couche-Tard's Upcoming Fiscal Year-End Results
  • WELIREG's Impact on Rare Tumors: Transforming Treatment Dynamics
  • Exciting Insights: Southwest Airlines at Upcoming Consumer Conference
  • IMUNON Secures $9.75 Million Through Strategic Private Placement
  • Houston American Energy Corp. Implements Strategic Stock Changes
  • Clear Blue Technologies Reports Strong Q1 2025 Financial Results
  • Astrotech Corporation Welcomes Jennifer Cañas as CFO
  • Eton Pharmaceuticals Gains FDA Nod for Unique Pediatric Therapy
  • Parkland Corporation Announces Strategic Arrangement with Sunoco
  • EQB Inc. Reports Strong Q2 Results with Higher Dividends
  • SCAN Triumphs with 2025 Hearst Health Prize for Innovation
  • TAT Technologies Launches Major Offering of Ordinary Shares
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site